WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

FDA clears Emboline's Emboliner, a TAVR filter tested head to head against Sentinel CraniUS clears a patient-specific cranial plate under K261058 Ropca clears its arthritis ultrasound robot for the US after four years in Europe Petal Surgical shows its histotripsy robot and says first-in-human is close FDA says it has never authorized a clear aligner sold without a prescription LUMA Vision clears a second VERAFEYE 510(k), adding catheter tracking and ablation marking FDA approves Abbott's TactiFlex Duo, one catheter that switches between pulsed field and RF Boston Scientific tells the SEC it will miss 2026 guidance after the August cyberattack Bioretec clears a headless bioabsorbable compression screw for hand and foot fixation FDA clears Emboline's Emboliner, a TAVR filter tested head to head against Sentinel CraniUS clears a patient-specific cranial plate under K261058 Ropca clears its arthritis ultrasound robot for the US after four years in Europe Petal Surgical shows its histotripsy robot and says first-in-human is close FDA says it has never authorized a clear aligner sold without a prescription LUMA Vision clears a second VERAFEYE 510(k), adding catheter tracking and ablation marking FDA approves Abbott's TactiFlex Duo, one catheter that switches between pulsed field and RF Boston Scientific tells the SEC it will miss 2026 guidance after the August cyberattack Bioretec clears a headless bioabsorbable compression screw for hand and foot fixation

510(k)

Ropca clears its arthritis ultrasound robot for the US after four years in Europe

MedDevice Startups Staff · 1 day ago · 2 min read · Via MassDevice

FDA cleared Ropca's ultrasound automation systems, the Danish company said September 9. Arthur, a robot, captures standardized ultrasound images of finger, hand and wrist joints. Diana, the AI software, analyzes them to support assessment of arthritic patients.

The system has been available in the European Union since 2022 and has completed more than 5,400 scans across six countries. Musculoskeletal ultrasound is slow and depends on who is holding the probe, and rheumatology clinics rarely have enough trained hands to run it at volume. CEO Johannes Schaeferhoff framed the clearance as an answer to capacity and consistency.

The interesting part is getting the robot and the reading software through together. Autonomous image capture carries mechanical and patient contact risk that the software guidances do not address, and it makes for a heavier file than an analysis algorithm on its own.

Questions & Answers

What did Ropca get FDA clearance for?

Ropca announced on September 9, 2026 that FDA cleared its ultrasound automation systems: Arthur, a robot that captures standardized ultrasound images of finger, hand and wrist joints, and Diana, the AI software that analyzes those images to support assessment of arthritic patients.

How long has the Ropca system been used in Europe?

Ropca's Arthur and Diana system has been available in the European Union since 2022 and has completed more than 5,400 scans across six countries, according to the Danish company.

What problem is Ropca's Arthur robot meant to solve in rheumatology?

Musculoskeletal ultrasound is slow and depends heavily on the operator, and rheumatology clinics rarely have enough trained staff to run it at volume. Ropca CEO Johannes Schaeferhoff framed the September 2026 FDA clearance as an answer to capacity and consistency, with faster access to specialist assessment.

← Back to Newly Cleared